tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CMPX Stock Latest News

Compass Therapeutics Announces Public Offering to Raise $112.5M
Company AnnouncementsCompass Therapeutics Announces Public Offering to Raise $112.5M
16d ago
8K
CMPX
Compass Therapeutics 33.3M share Spot Secondary priced at $3.00
PremiumThe Fly
Compass Therapeutics 33.3M share Spot Secondary priced at $3.00
16d ago
CMPX
Compass Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Compass Therapeutics announces common stock offering, no amount given
17d ago
CMPX
Compass Therapeutics price target raised to $12 from $10 at Guggenheim
PremiumThe Fly
Compass Therapeutics price target raised to $12 from $10 at Guggenheim
17d ago
CMPX
Compass Therapeutics Faces Financial Risks Amid Global Economic Uncertainty and Trade Tensions
PremiumCompany Announcements
Compass Therapeutics Faces Financial Risks Amid Global Economic Uncertainty and Trade Tensions
17d ago
CMPX
Compass Therapeutics Reports Q2 2025 Financials and Clinical Progress
PremiumCompany AnnouncementsCompass Therapeutics Reports Q2 2025 Financials and Clinical Progress
17d ago
CMPX
Compass Therapeutics: Promising Pipeline and Strong Financial Outlook Drive Buy Rating
Premium
Ratings
Compass Therapeutics: Promising Pipeline and Strong Financial Outlook Drive Buy Rating
18d ago
CMPX
Compass Therapeutics Reports Promising Q2 2025 Results
Premium
Company Announcements
Compass Therapeutics Reports Promising Q2 2025 Results
18d ago
8K
CMPX
Compass Therapeutics reports Q2 EPS (14c), consensus (12c)
PremiumThe Fly
Compass Therapeutics reports Q2 EPS (14c), consensus (12c)
18d ago
CMPX
Compass Therapeutics announces anticipated cash runway into 2027
PremiumThe Fly
Compass Therapeutics announces anticipated cash runway into 2027
18d ago
CMPX
Compass Therapeutics: Promising Clinical Trials and Strategic Confidence Drive Buy Rating
PremiumRatings
Compass Therapeutics: Promising Clinical Trials and Strategic Confidence Drive Buy Rating
2M ago
CMPX
Promising Outlook for Compass Therapeutics: Buy Rating Backed by Tovecimig’s Potential and Strategic Positioning
PremiumRatings
Promising Outlook for Compass Therapeutics: Buy Rating Backed by Tovecimig’s Potential and Strategic Positioning
2M ago
CMPX
Compass Therapeutics resumed with an Outperform at Raymond James
PremiumThe FlyCompass Therapeutics resumed with an Outperform at Raymond James
2M ago
CMPX
Compass Therapeutics Completes Phase 2 Study on CTX-009 for Metastatic Colorectal Cancer
Premium
Company Announcements
Compass Therapeutics Completes Phase 2 Study on CTX-009 for Metastatic Colorectal Cancer
2M ago
CMPX
Compass Therapeutics Confirms Directors at Annual Meeting
Premium
Company Announcements
Compass Therapeutics Confirms Directors at Annual Meeting
3M ago
8K
CMPX
Compass Therapeutics management to meet virtually with Piper Sandler
PremiumThe Fly
Compass Therapeutics management to meet virtually with Piper Sandler
3M ago
CMPX
Compass Therapeutics: Positive Drug Data and Strategic Expansion Justify Buy Rating
PremiumRatings
Compass Therapeutics: Positive Drug Data and Strategic Expansion Justify Buy Rating
4M ago
CMPX
Compass Therapeutics price target lowered to $10 from $12 at Guggenheim
PremiumThe Fly
Compass Therapeutics price target lowered to $10 from $12 at Guggenheim
4M ago
CMPX
Compass Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Compass Therapeutics Reports Q1 2025 Financial Results
4M ago
CMPX
Compass Therapeutics reports Q1 EPS (12c), consensus (11c)
PremiumThe FlyCompass Therapeutics reports Q1 EPS (12c), consensus (11c)
4M ago
CMPX
Compass Therapeutics has anticipated cash runway into 2027
Premium
The Fly
Compass Therapeutics has anticipated cash runway into 2027
4M ago
CMPX
Compass Therapeutics presents data on efficacy of CTX-471
Premium
The Fly
Compass Therapeutics presents data on efficacy of CTX-471
4M ago
CMPX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >